Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study (Q82931090)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2006

Language	Label	Description	Also known as
English	Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study	scientific article published on 01 January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Pavlos Papakostas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dimitrios Tsavdaridis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paris Kosmidis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Athanassios Sakantamis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dimitrios Janinis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dimosthenis Skarlos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dimitrios Bafaloukos

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Aristotelis Bamias

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nikos Xiros

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

George Fountzilas

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

26-31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557433%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

https://scigraph.springernature.com/pub.10.1007/s10120-005-0353-4

0 references

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line chemotherapy in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557433

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82931090&oldid=2051699543"